Abstract
The women during the menopause period have an increased tendency for the obesity, which represents the more fat production than during the premenopausal period. Although this is not beneficial overall, it could provide a compensatory source for the estrogen production for the menopausal women. So it would be meaningful to find an agent that could inhibit the fat production while does not disturb the total estrogen production by fat tissues. In the present study, the effect of oleanolic acid (OA) on the fat production and the total estrogen production of the differentiating mouse preadipocyte 3T3-L1 as well as the mechanisms behind those effects were preliminarily investigated. The cell line 3T3-L1 was chosen as the model cell because it is usually used for the research about the obesity. During the induced differentiation of 3T3-L1 cells, cells were intervened continuously with OA. The fat production was determined with the oil red staining assay and the total estrogen production was measured with the ELISA assay. Finally, the expression patterns for important genes of the fat production and the estrogen production were studied, respectively with the real-time fluorescence quantitative PCR (qPCR). The results showed that for the differentiating 3T3-L1 cells, OA could significantly inhibit the fat production and did not disturb the total estrogen production significantly. In the mechanism studies, OA was found to significantly down-regulate ACC, the key gene for fat synthesis, which could explain the inhibitory effect of OA on the fat production; OA was also found to significantly up-regulate CYP11A1, CYP17, CYP19, the key genes for the estrogen synthesis and significantly down-regulate CYP1A1, the key gene for the estrogen decomposition, which preliminarily explained the lack of the effect of OA on the total estrogen production. In conclusion, OA was found able to inhibit the fat production while maintaining the total estrogen level and the mechanisms for the above findings were preliminarily clarified, which suggests that OA may be useful to treat the menopausal obesity.
Similar content being viewed by others
References
Sharma S, Bakshi R, Tandon VR, Mahajan A. Postmenopausal obesity. JK Sci. 2008;10:105–6.
Rosano GM, Vitale C, Marazzi G, Volterrani M. Menopause and cardiovascular disease: the evidence. Climacteric. 2007;10:19–24.
Dubnov-Raz G, Pines A, Berry EM. Diet and lifestyle in managing postmenopausal obesity. Climacteric. 2007;10:38–41.
Samat A, Rahim A, Barnett A. Pharmacotherapy for obesity in menopausal women. Menopause Intl. 2008;14:57–62.
Lemieux C, Picard F, Labrie F, Richard D, Deshaies Y. The estrogen antagonist EM-652 and dehydroepiandrosterone prevent diet- and ovariectomy-induced obesity. Obesity Res. 2003;11:477–90.
Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol. 2003;86:225–30.
Sørensen MB, Rosenfalck AM, Højgaard L, Ottesen B. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy. Obesity Res. 2001;9:622–6.
Turgeon JL, Carr MC, Maki PM, Mendelsohn ME, Wise PM. Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: insights from basic science and clinical studies. Endocrine Rev. 2006;27:575–605.
Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. J Am Med Assoc. 2004;291:1701–12.
Perez-Camino MC, Cert A. Quantitative determination of hydroxyl pentacyclic triterpene acids in vegetable oils. J Agric Food Chem. 1999;47:1558–62.
Zhang SY, Li Z. Progress in oleanolic acid research. Food Ferment Tech. 2010;4:20–4.
Sung HY, Kang SW, Kim JL, Li J, Lee ES, Gong JH, et al. Oleanolic acid reduces markers of differentiation in 3T3-L1 adipocytes. Nutr Res. 2010;30:831–9.
Zhang YN, Zhang W, Hong D, Shi L, Shen Q, Li JY, et al. Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities. Bioorg Med Chem. 2008;16:8697–705.
Ramirez-Zacarias JL, Castro-Munozledo F, Kuri-Harcuch W. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry. 1992;97:493–7.
Huang P, Zhou HH. A study of relationship between estrogen synthesis and metabolism involved enzymes and breast cancer susceptibility. J Oncol. 2004;10:267–70.
Jayakumar A, Chirala SS, Chinault AC, Baldini A, Abu-Elheiga L, Wakil SJ. Isolation and chromosomal mapping of genomic clones encoding the human fatty acid synthase gene. Genomics. 1995;23:420–4.
Tong L. Acetyl-coenzyme A carboxylase: crucial metabolic enzyme and attractive target for drug discovery. Cell Mol Life Sci. 2005;62:1784–803.
Strålfors P, Belfrage P. Phosphorylation of hormone-sensitive lipase by cyclic AMP-dependent protein kinase. J Biol Chem. 1983;258:15146–52.
Harbitz I, Kristensen T, Kran S, Davies W. Isolation and sequencing of porcine lipoprotein lipase cDNA and its use in multiallelic restriction fragment length polymorphism detection. Anim Genet. 1992;23:517–22.
Green H, Meuth M. An established pre-adipose cell line and its differentiation in culture. Cell. 1974;3:127–33.
Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev. 1998;78:783–809.
Hiroshi M, Jun I, Teruki K, Kenshi S, Katsuhisa H. Bisphenol a accelerates terminal differentiation of 3T3-l1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol Sci. 2005;84:319–27.
Nelson LR, Bulun SE. Estrogen production and action. J Am Acad Dermatol. 2001;45(3 Suppl):S116–24.
Sung HY, Kang SW, Kim JL, Li J, Lee ES, Gong JH, et al. Oleanolic acid reduces markers of differentiation in 3T3-L1 adipocytes. Nutr Res. 2010;30:831–9.
Shin S, Wakabayashi J, Yates MS, Wakabayashi N, Dolan PM, Aja S, et al. Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide. Eur J Pharmacol. 2009;620:138–44.
Kim HS, Sung HY, Kim MS, Kim JL, Kang MK, Gong JH, et al. Oleanolic acid suppresses resistin induction in adipocytes by modulating Tyk-STAT signaling. Nutr Res. 2013;33:144–53.
Sánchez-Wandelmer J, Dávalos A, Herrera E, Giera M, Cano S, de la Peña G, et al. Inhibition of cholesterol biosynthesis disrupts lipid raft/caveolae and affects insulin receptor activation in 3T3-L1 preadipocytes. Biochim Biophys Acta. 2009;1788:1731–9.
Yamada K, Harada N. Expression of estrogen synthetase (P-450 aromatase) during adipose differentiation of 3T3-L1 cells. Biochem Biophys Res. 1990;169:531–6.
Li J, Daly E, Campioli E, Wabitsch M, Papadopoulos V. De novo synthesis of steroids and oxysterols in adipocytes. J Biol Chem. 2014;289:747–64.
Berg JM, Tymoczko JL, Stryer L. Biochemistry. 5th ed., Section 26.3New York: W. H. Freeman; 2002.
Acknowledgments
We sincerely thank Madam Peng Wenzhen of Sichuan University for the cultured cells and the cell culturing. The National Program on Key Basic Research Project of China (973 Program, No. 2010Cb530403), Experimental Technology Program of Chengdu University of Traditional Chinese Medicine (No. 063003) and the University Foundation of Chengdu University of Traditional Chinese Medicine (No. ZRMS201248) supported this work.
Conflict of interest
We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work. There is no professional or other personal interest of any nature or kind in any product, service and/or company that could be construed as influencing the position presented in, or the review of, the manuscript entitled, ‘‘the study of oleanolic acid on the estradiol production and the fat production of mouse preadipocyte 3T3-L1 in vitro’’.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wan, Q., Lu, H., Liu, X. et al. The study of oleanolic acid on the estrodiol production and the fat production of mouse preadipocyte 3T3-L1 in vitro. Human Cell 28, 5–13 (2015). https://doi.org/10.1007/s13577-014-0097-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13577-014-0097-8